Scancell Holdings PLC (SCLP)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
9.60p
Buy
10.50p
-0.342p (-3.40%)
Scancell Holdings PLC is a biopharmaceutical company focused on the cancer therapeutics market. The company's principal activity consists of the discovery and development of monoclonal antibodies and vaccines for the treatment of cancer.
Prices updated at 07 May 2025, 11:48 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
14 Apr 202501 Apr 202520 Feb 202517 Feb 202530 Jan 202523 Jan 202509 Jan 202509 Dec 202405 Dec 202404 Dec 2024
Key dates
| Forecast date | |
|---|---|
| Half yearly results | Jan 2026 |
| Annual general meeting | Oct 2025 |
| Final results | Sep 2025 |
| Annual report | Sep 2025 |
| Previous date | |
|---|---|
| Half yearly results | Jan 2025 |
| Annual general meeting | Oct 2024 |
| Final results | Sep 2024 |
| Annual report | Sep 2024 |
Company reports
30 Apr 2023
Annual Report 